Miano, associate director of the Aab Cardiovascular Research Institute at the University of Rochester Medical Center had identified a number of genes that were activated or turned on by retinoids, one of which was AKAP12.
Because research in the cancer field suggested it was a tumor suppressor gene, named for its ability to hinder cancer cell growth, Miano honed in on AKAP12 to see if it might be a target of retinoids in the context of vascular disease.